Alto Neuroscience Secures New U.S. Patent for ALTO-207 Method of Treatment in Depression
The issuance of a method-of-treatment patent for ALTO-207 marks a significant expansion of Alto Neuroscience’s intellectual property assets targeting depression therapies.
Alto Neuroscience has bolstered its intellectual property portfolio with the grant of a new U.S. patent covering a method of treatment using ALTO-207 for depression. This development underscores the company’s commitment to advancing innovative therapeutic approaches in mental health and protecting its proprietary tech…